first-in-class, and next-in-class drugs with all drugs (included cellular and gene therapies) approved in 2023 taken as 100%. Where available, the International Nonproprietary Name stems in drug names have been highlighted by underlining based on the WHO...
Soriano-Disla, J.M.; Janik, L.J.; Viscarra Rossel, R.A.; Macdonald, L.M.; McLaughlin, M.J. The Performance of Visible, Near-, and Mid-Infrared Reflectance Spectroscopy for Prediction of Soil Physical, Chemical, and Biological Properties. Appl. Spectrosc. Rev. 2014, 49, 139–186. ...